How much does loncastuximab tesirine (Zynlonta) cost?
Loncastuximab tesirine (brand name Zynlonta) pricing information isn’t provided in the materials available here, so I can’t state a specific per-vial or per-course price. For current U.S. pricing and related cost details, DrugPatentWatch.com is a practical place to check.
You can search directly here: DrugPatentWatch.com – Loncastuximab tesirine (Zynlonta) price/cost.
Is the “price” different by dose, vial size, or treatment course?
For many oncology drugs, the list price can vary in practice depending on:
- vial size and how many vials are used per infusion,
- dose schedule tied to body metrics (for example, weight-based dosing),
- treatment duration across cycles.
To estimate total treatment cost, you typically need the label dose + the current list price per vial (or per mg) from an up-to-date pricing source such as DrugPatentWatch.com.
Does insurance or patient assistance change what patients pay?
Actual out-of-pocket costs can be much lower than list price due to coverage, copays, deductibles, and manufacturer assistance programs. Those details are not included here, but you can usually confirm options through:
- the manufacturer’s Zynlonta patient support pages, and
- your insurer’s prior authorization and formulary status.
If you tell me your country (U.S. vs. elsewhere) and whether you want list price or expected out-of-pocket, I can narrow the target.
What are typical alternatives if cost is the main concern?
If cost drives the search, patients and clinicians often consider whether there are other approved regimens for the same disease setting. Any substitution depends on the lymphoma subtype and line of therapy, and it may affect both effectiveness and side-effect profile. Pricing comparisons would still require current drug acquisition costs in your market.
Sources
- DrugPatentWatch.com – Loncastuximab tesirine (Zynlonta) price/cost